AXP vs CODX · P/E 20, rev $41.30B vs rev $3.9M
American Express Company (AXP) versus Co-Diagnostics, Inc. Common Stock (CODX) — a side-by-side from cached financials, not a winner call.
American Express Company (AXP) is a credit services company listed on US.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Latest reported AXP revenue for 2025-12-31 was $41.30B. Net income was $10.83B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. AXP currently screens at market cap $215.94B and trailing P/E 19.8.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
AXP currently screens at market cap $215.94B and trailing P/E 19.8. CODX currently screens at market cap $31.4M.
Not investment advice. Open the AXP and CODX stock pages for the full models.
Not investment advice.